Despite its rare occurrence, early diagnosis and appropriate treatment for neonatal herpes simplex virus infection are mandatory due to its high morbidity and mortality. In Korea, there has been no epidemiologic data on neonatal herpes simplex virus infection, and even case reports are rare. We observed a 16-day-old neonate who presented with fever and seizures. We diagnosed her with meningoencephalitis caused by herpes simplex virus type 2 based on the polymerase chain reaction test, and treated her with intravenous acyclovir and anticonvulsants. The seroprevalence of herpes simplex virus type 2 sharply increases in women in their 30s, and the average age for childbirth has increased to older than 30 years of age in Korea; we therefore expect that the incidence of neonatal herpes simplex virus type 2 infection will rise in Korea, and more attention should be directed to neonatal herpes simplex virus type 2 infection. We report this newborn patient's case along with a literature review.
Introduction

Neonatal herpes simplex virus (HSV) infection
occurs at a rate of 8-60 neonates per 100,000 live births in the United States 1) . In Korea, no epidemiologic data exists on neonatal HSV infection, including neonatal HSV type 2 infection, which comprises about 80% of cases [2] [3] [4] . In addition, case reports on neonatal HSV infection are rare in Korea.
As neonatal HSV infection has no specific charac-teristics that distinguish it from severe bacterial infection 4) , each case report provides valuable information on the disease and helps improve proper diagnosis and treatment. We report a case of a 16-day-old neonate who presented with fever and seizure. This neonate was diagnosed with HSV type 2 meningoencephalitis through polymerase chain reaction (PCR) in the cerebrospinal fluid (CSF) and was treated with intravenous acyclovir.
Case Report
A 16-day-old neonate presented with fever and clonic movements of her left arm and leg. She had been febrile since the previous day, but she was neither irritable nor lethargic. The clonic move- A second LP, performed after seven days of intravenous acyclovir therapy, still revealed pleocytosis, increased protein levels and decreased glucose level, but HSV type 2 PCR was negative (Table 1 ). On hospital day 11, it was reported that her blood and CSF cultures which were performed before intravenous acyclovir therapy were negative for HSV.
The patient completed a 21-day course of intravenous acyclovir therapy without any complications or drug adverse effects, and a third LP was performed on hospital day 24. The third LP showed improved results: decrease in CSF WBC count and protein level and slight increase in glucose level (Table 1) . Visual and auditory evoked potentials were normal. The patient was discharged from hospital on hospital day 27 while continuing oral anticonvulsant therapy (levetiracetam 25 mg/kg and phenobarbital 5 mg/kg twice a day). An EEG repeated at three months after diagnosis showed no abnormal findings (Fig. 1B) , and anticonvulsant therapy was finished at 4 months after diagnosis of meningoencephalitis. Brain MRI was also repeated three months after diagnosis, which unfortunately showed focal encephalomalacia in both frontal lobes (Fig. 2B ) and multifocal old hemorrhages in the cerebral and cerebellar parenchyma ( Fig. 2C and   2D ). At seven months of age, her body weight was . This is in contrast to HSV infection in children and adults, which is usually caused by HSV type 1 1) . Kim et al. 5) reported that the sero- . Shin et al. 8) . However, the rate increases to 25-50% if the mother is first infected with HSV during pregnancy 1) . . Accordingly, we can speculate that neonatal HSV type 2 infection will occur more frequently since the average age of childbirth overlaps with the age when women are most frequently first infected with HSV type 2. Therefore, more frequent attention should be directed to neonatal HSV type 2 infection, even though it has been rarely reported.
Symptoms and signs of neonatal HSV infection
usually develop at 8-12 days of life as non-specific manifestations which are difficult to differentiate from severe bacterial infections 3, 4, 10) . Herpetic skin lesions do not occur in 18-69% of the cases, only 30% of HSV-infected mothers present symptoms and signs suggesting HSV infection at delivery, and 80-89% of the mothers do not complain of genital herpes 2, 4) . Therefore, supplemental laboratory tests are necessary for a definitive diagnosis of neonatal HSV infection. Our patient also did not show any skin lesions, and the mother had no previous history of genital herpes and did not show any skin and mucosal lesions consistent with HSV infection on examination performed during the patient's hospitalization. Accordingly, we assumed that the patient was exposed to asymptomatically excreted HSV during delivery. PCR is the most sensitive laboratory test, though antibody assays and virus culture may be used 1) . Due to the probability of a false negative PCR result in the early phase of infection, repeated PCR may be necessary for patients who show a negative initial result but are likely to be infected with HSV 1) .
Neonatal HSV infection is divided into three categories according to the extent of disease; disseminated infection, CNS infection and SEM (skin, eyes, mouth) infections comprise 9-25%, 30-75%
and 19-45% of cases, respectively 4, 11) . The highest mortality rate, 30%, is observed in disseminated infection; in addition, up to 70% of neonates who survive CNS infection will have sequelae 1) . Considering the occasional development of repeated CNS symptoms after neonatal CNS infection 1) and the occurrence of acute retinal necrosis several years after the initial CNS infection 12) , long-term observation is mandatory for patients who experienced neonatal HSV infection. MRI is more valuable than computed tomography as a brain imaging modality 13) . Repeated brain imaging may also be necessary, as the initial brain MRI within a week of HSV diagnosis may be unremarkable or may show only diffusion defects 3, 13) . However, definite conventional T1 or T2 abnormalities may be observed in repeated imaging studies 3, 13) , as observed in our patient.
Although two-thirds of neonates with HSV encephalitis showed abnormal brain imaging findings in temporal lobes, less than one-third of the neonates showed brain lesions limited into temporal lobes and two-thirds of the neonates showd multifocal brain lesions 13) . Schleede et al. 3) reportd that brain lesions involving parietal or occipital lobes were more frequent than lesions involving temporal lobes in neonates with CNS HSV infection, and this finding was contrary to the cases of non-neonatal HSV infection. . SEM infections should be treated with intravenous acyclovir for 14 days because it can progress to CNS or disseminated infection 1) . Some researchers reported that long-term oral acyclovir therapy lasting for six months to two years improved neurodevelopmental outcomes in neonates who experienced disseminated or CNS HSV infection 14, 15) .
In our patient, antiviral therapy was initiated within three days of symptoms and seizures responded well to anticonvulsant therapy. Therefore, oral acyclovir suppression therapy following intravenous therapy was not given. . Others insist on a selective HSV test and empirical therapy for febrile neonates with pleocytosis on CSF examination 16) . In Korea, where there is the potential for increasing incidence of neonatal HSV type 2 infection, a multicenter or nationwide epidemiologic survey on neonatal HSV infection should be performed to establish appropriate diagnostic and therapeutic strategies. 
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